GENEVA, May 3 -- SHIHUIDA PHARMACEUTICAL GROUP (JILIN) CO., LTD. (No. 999, High-Tech Industry ParkBaishan, Jilin 134399), 施慧达药业集团（吉林）有限公司 (中国吉林省白山市高新技术产业园999号) filed a patent application (PCT/CN2025/129332) for "USE OF ANTI-OX40 ANTIBODY IN TREATMENT OF DERMATITIS" on Oct 22, 2025. With publication no. WO/2026/086834, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...